Copy For Citation
GROM A. A., Ilowite N. T., PASCUAL V., BRUNNER H. I., MARTINI A., LOVELL D., ...More
ARTHRITIS & RHEUMATOLOGY, vol.68, no.1, pp.218-228, 2016 (SCI-Expanded)
Article / Article
ARTHRITIS & RHEUMATOLOGY
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Hacettepe University Affiliated:
ObjectiveIn pivotal trials, canakinumab has been shown to be effective in the treatment of systemic juvenile idiopathic arthritis (JIA), but reported adverse events have included macrophage activation syndrome (MAS). This study was undertaken to assess the impact of canakinumab on MAS incidence.